SCHEMBL7925152

SCHEMBL7925152

CC1(C)C(=O)N(O)C(C)(C)N1O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14227254 0.77 KDM4E (0.31)
SCHEMBL7163965 0.70 LMNA (0.37) POLB
SCHEMBL14227253 0.66 AR (0.35)
SCHEMBL1811430 0.65 KDM4E (0.33)
SCHEMBL11772475 0.62 MGLL (0.38) POLB
SCHEMBL11773716 0.62 MGLL (0.38) POLB
SCHEMBL11774797 0.61 POLB (0.32) POLB
SCHEMBL31456557 0.60
SCHEMBL16732465 0.60
SCHEMBL14227264 0.60 PTGS1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1082280-A1 METHOD FOR STABILIZING UNSATURATED ORGANIC COMPOUNDS FROM POLYMERIZATION UNIROYAL CHEMICAL COMPANY, Inc. (US) 2001-03-14 EP claimed
WO-1999061396-A1 METHOD FOR STABILIZING UNSATURATED ORGANIC COMPOUNDS FROM POLYMERIZATION UNIROYAL CHEMICAL COMPANY, INC. (US) 1999-12-02 WO claimed
US-20090274947-A1 Imidazolidinone nitroxides as electrode materials for energy storage devices CIBA CORP. 2009-11-05 US disclosed
US-6287483-B1 MIXING WITH AMINOPYRROLIDINE COMPOUND UNIROYAL CHEMICAL COMPANY, INC. 2001-09-11 US disclosed
EP-1082280-A1 METHOD FOR STABILIZING UNSATURATED ORGANIC COMPOUNDS FROM POLYMERIZATION UNIROYAL CHEMICAL COMPANY, Inc. (US) 2001-03-14 EP disclosed
WO-1999061396-A1 METHOD FOR STABILIZING UNSATURATED ORGANIC COMPOUNDS FROM POLYMERIZATION UNIROYAL CHEMICAL COMPANY, INC. (US) 1999-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090274947-A1 Imidazolidinone nitroxides as electrode materials for energy storage devices IDH2, NQO1, NOX1 POLB 1696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.